Last updated 5 days ago

A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)

12500 patients around the world
Available in Brazil, Argentina, United States
Eli Lilly and Company
5Research sites
12500Patients around the world
This study is for people with
Elevated Lipoprotein A
Cardiovascular disease
Established cardiovascular disease
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
STAT Research - CABA
STAT Research - CABA
Recruiting
Av. Callao 875, CABA, Buenos Aires
Centro Medico Dra. Laura Maffei - Investigación Clínica Aplicada
Ciudad Autónoma De Buenos Aires, Argentina, C1425AGC
Hospital Moinhos de Vento
R. Ramiro Barcelos, 910 - Floresta, Porto Alegre - RS, 90035-001, Brazil
Instituto Brasil de Pesquisa Clínica - IBPClin
R. da Glória, 344 - Glória, Rio de Janeiro - RJ, 20241-180
CPQuali Pesquisa Clínica
Avenida Angélica, 916 Conjunto 506 - São Paulo 01228-000
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy